Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA

References

• GrandeIBerkMBirmaherBVietaEBipolar disorderLancet2016387100271561157226388529
   PubMed Web of Science ®Google Scholar
• ForteABaldessariniRJTondoLVazquezGHPompiliMGirardiPLong-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disordersJ Affect Disord2015178717825797049
   PubMed Web of Science ®Google Scholar
• MerikangasKRJinRHeJPPrevalence and correlates of bipolar spectrum disorder in the world mental health survey initiativeArch Gen Psychiatry201168324125121383262
   PubMed Web of Science ®Google Scholar
• DemlandJAJingYKeltonCMGuoJJLiHWiglePRUse pattern and off-label use of atypical antipsychotics in bipolar disorder 1998–2002Am Health Drug Benefits20092418419125126291
   PubMedGoogle Scholar
• DolsAKupkaRWvan LammerenABeekmanATSajatovicMStekMLThe prevalence of late-life mania: a reviewBipolar Disord201416211311823919307
   PubMed Web of Science ®Google Scholar
• GrunzeHVietaEGoodwinGMWFSBP Task Force on Treatment Guidelines for Bipolar DisordersThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorderWorld J Biol Psychiatry201314315421923480132
   PubMed Web of Science ®Google Scholar
• MalhiGSBassettDBoycePRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disordersAust N Z J Psychiatry201549121087120626643054
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHParikhSVCanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Bipolar Disord201315114423237061
   PubMed Web of Science ®Google Scholar
• Department of Veterans Affairs (VA), Department of Defense (DOD)Clinical practice guideline for clinical management of bipolar disorder in adultsWashingtonVA/DoD2010 Available from: http://www.healthquality.va.gov/guidelines/MH/bd/bd_306_sum.pdfAccessed October 04, 2016
   Google Scholar
• MillerNHCompliance with treatment regimens in chronic asymptomatic diseasesAm J Med19971022A43499217586
   PubMedGoogle Scholar
• GarciaSMartinez-CengotitabengoaMLopez-ZurbanoSAdherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic reviewJ Clin Psychopharmacol201636435537127307187
   PubMed Web of Science ®Google Scholar
• VelliganDISajatovicMHatchAKramataPDochertyJPWhy do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illnessPatient Prefer Adherence20171144946828424542
   PubMed Web of Science ®Google Scholar
• LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationBMJ2009339b270019622552
   PubMed Web of Science ®Google Scholar
• BaldessariniRHenkHSklarAChangJLeahyLPsychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherencePsychiatr Serv200859101175118318832504
   PubMed Web of Science ®Google Scholar
• BaldessariniRJLeahyLArconaSGauseDZhangWHennenJPatterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disordersPsychiatr Serv2007581859117215417
   PubMed Web of Science ®Google Scholar
• BauerMSMillerCJLiMBajorLALeeAA population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorderBipolar Disord201618648148927650468
   PubMed Web of Science ®Google Scholar
• BergerAEdelsbergJSandersKNAlvirJMMychaskiwMAOsterGMedication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort studyBMC Psychiatry2012129922856540
   PubMed Web of Science ®Google Scholar
• BurnsMEBuschABMaddenJMEffects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiariesPsychiatr Serv201465332332924337444
   PubMed Web of Science ®Google Scholar
• BuschABLingDFrankRGGreenfieldSFChanges in the quality of care for bipolar I disorder during the 1990sPsychiatr Serv2007581273317215409
   PubMed Web of Science ®Google Scholar
• ChenWDeveaugh-GeissAMPalmerLPrincicNChenYTPatterns of atypical antipsychotic therapy use in adults with bipolar 1disorder in the USAHum Psychopharmacol201328542843723861367
   PubMed Web of Science ®Google Scholar
• CitromeLKalsekarIGuoZLaubmeierKHebdenTDiagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysisClin Ther201335121867187524119767
   PubMed Web of Science ®Google Scholar
• DeppCOjedaVDMastinWUnutzerJGilmerTPTrends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001–2004Psychiatr Serv200859101169117418832503
   PubMed Web of Science ®Google Scholar
• DusetzinaSBGaynesBNWeinbergerMFarleyJFSleathBHansenRAReceipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorderPsychiatr Serv201162121443144922193791
   PubMed Web of Science ®Google Scholar
• DusetzinaSBWeinbergerMGaynesBNFarleyJFSleathBHansenRAPrevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescentsPharmacotherapy201232121085109423208835
   PubMed Web of Science ®Google Scholar
• HassanMMadhavanSSKalsekarIDComparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorderAnn Pharmacother200741111812181817925501
   PubMed Web of Science ®Google Scholar
• HuangHGorenJLChanYFPharmacologic management of bipolar disorder in a Medicare Advantage populationPsychosomatics201455657257725016355
   PubMed Web of Science ®Google Scholar
• LageMJHassanMKThe relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective studyAnn Gen Psychiatry20098719226463
   PubMedGoogle Scholar
• LangKKornJMuserEChoiJCAbouzaidSMenzinJPredictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychoticsJ Med Econ201114221722621370989
   PubMedGoogle Scholar
• RascatiKLRichardsKMOttCAAdherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorderPsychiatr Serv20116291032104021885581
   PubMed Web of Science ®Google Scholar
• SajatovicMValensteinMBlowFGanoczyDIgnacioRTreatment adherence with lithium and anticonvulsant medications among patients with bipolar disorderPsychiatr Serv200758685586317535948
   PubMed Web of Science ®Google Scholar
• SeaburySAGoldmanDPKalsekarISheehanJJLaubmeierKLakdawallaDNFormulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in MedicaidAm J Manag Care2014202e52e6024738555
   PubMed Web of Science ®Google Scholar
• AlexanderGCGallagherSAMascolaAMoloneyRMStaffordRSIncreasing off-label use of antipsychotic medications in the United States, 1995–2008Pharmacoepidemiol Drug Saf201120217718421254289
   PubMed Web of Science ®Google Scholar
• BaldessariniRJPerryRPikeJFactors associated with treatment non-adherence among US bipolar disorder patientsHum Psychopharmacol20082329510518058849
   PubMed Web of Science ®Google Scholar
• BatesJAWhiteheadRBolgeSCKimECorrelates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional surveyPrim Care Companion J Clin Psychiatry2010125
   Google Scholar
• BlancoCComptonWMSahaTDEpidemiology of DSM-5 bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions – IIIJ Psychiatr Res20168431031727814503
   PubMed Web of Science ®Google Scholar
• MerikangasKRAkiskalHSAngstJLifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replicationArch Gen Psychiatry200764554355217485606
   PubMed Web of Science ®Google Scholar
• DennehyEBBauerMSPerlisRHKoganJNSachsGSConcordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorderPsychopharmacol Bull2007403728418007570
   PubMedGoogle Scholar
• FreelandKNCogdillBRRossCAAdherence to evidence-based treatment guidelines for bipolar depression in an inpatient settingAm J Health Syst Pharm20157223 Suppl 3S156S16126582302
   PubMed Web of Science ®Google Scholar
• HooshmandFMillerSDoreJTrends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000–2011J Affect Disord201415528328724314912
   PubMed Web of Science ®Google Scholar
• PerlisRHOstacherMJMiklowitzDJClinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD studyJ Clin Psychiatry201071329630320331931
   PubMed Web of Science ®Google Scholar
• SajatovicMValensteinMBlowFCGanoczyDIgnacioRVTreatment adherence with antipsychotic medications in bipolar disorderBipolar Disord20068323224116696824
   PubMed Web of Science ®Google Scholar
• UnutzerJSimonGPabiniakCBondKKatonWThe treated prevalence of bipolar disorder in a large staff-model HMOPsychiatr Serv1998498107210789712215
   PubMed Web of Science ®Google Scholar
• GonzalezHMVegaWAWilliamsDRTarrafWWestBTNeighborsHWDepression care in the United States: too little for too fewArch Gen Psychiatry2010671374620048221
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE)Bipolar disorder (update): the management of bipolar disorder in adults, children and adolescents in primary and secondary careClinical Guideline1852014 Available from: https://www.nice.org.uk/guidance/cg185Accessed October 04, 2016
   Google Scholar
• PerlisRHUse of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of cliniciansCurr Med Res Opin200723346747517355728
   PubMed Web of Science ®Google Scholar
• TohenMCalabreseJRSachsGSRandomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineAm J Psychiatry2006163224725616449478
   PubMed Web of Science ®Google Scholar
• Whalley BuonoEVrijensBBosworthHBLiuLZZulligLLGrangerBBComing full circle in the measurement of medication adherence: opportunities and implications for health carePatient Prefer Adherence2017111009101728652710
   PubMed Web of Science ®Google Scholar
• HoertelNLe StratYLavaudPDubertretCLimosinFGeneralizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related ConditionsJ Clin Psychiatry201374326527023561233
   PubMed Web of Science ®Google Scholar
• BuschABNeelonBZelevinskyKHeYNormandSLAccurately predicting bipolar disorder mood outcomes: implications for the use of electronic databasesMed Care201250431131922210540
   PubMed Web of Science ®Google Scholar
• JiangYNiWEstimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalizationPharmacotherapy201535981382226406773
   PubMed Web of Science ®Google Scholar
• VelliganDIWeidenPJSajatovicMExpert Consensus Panel on Adherence Problems in Serious and Persistent Mental IllnessThe expert consensus guideline series: adherence problems in patients with serious and persistent mental illnessJ Clin Psychiatry200970Suppl 4146 quiz 47–4819686636
   PubMed Web of Science ®Google Scholar